|3.||Whooping Cough (Pertussis)
|1.||Centers for Disease Control and Prevention (CDC): 39 articles (06/2015 - 03/2000)|
|2.||Sutter, Roland W: 32 articles (12/2015 - 04/2003)|
|3.||Pallansch, Mark A: 25 articles (11/2015 - 10/2004)|
|4.||Thompson, Kimberly M: 22 articles (06/2015 - 12/2006)|
|5.||Aylward, R Bruce: 17 articles (12/2015 - 01/2004)|
|6.||Aaby, Peter: 17 articles (10/2014 - 01/2002)|
|7.||Bakker, Wilfried A M: 15 articles (08/2015 - 04/2011)|
|8.||Duintjer Tebbens, Radboud J: 15 articles (06/2015 - 12/2006)|
|9.||Shimizu, Hiroyuki: 13 articles (05/2013 - 07/2005)|
|10.||Smith, Philip J: 13 articles (07/2011 - 01/2004)|
01/01/1978 - "Killed-virus poliomyelitis vaccines have proved to be effective in certain countries that have used them exclusively; these are small countries with excellent public health systems, where coverage by the killed vaccine has been wide and frequent. "
12/01/1986 - "However, simultaneous administration of polio and RIT 4237 vaccines caused a significant reduction of the antibody response to rotavirus but not to polioviruses types 1 and 3."
01/01/2015 - "The new endgame strategic plan calls for stepwise removal of the type 2 poliovirus component from trivalent oral vaccines, because type 2 wild poliovirus appears to have been eradicated (since 1999) and yet is the main cause of cVDPV outbreaks and approximately 40% of vaccine-associated paralytic polio cases. "
01/16/2014 - "Oral vaccines for polio (OPV) and rotavirus are less effective in children in the developing world. "
10/01/2014 - "Techniques used in this study represent new approaches for the characterization of inactivated PV products and could be useful in developing improved methods for the production and quality control testing of inactivated polio vaccines. "
01/01/2011 - "This study showed high levels of surveillance performance with some challenges in reverse the cold chain system, the continuation and sustained AFP case detection, prompt investigation and response, improvement in the reserve cold chain system would achieve optimal standards recommended by WHO and might provide a good model for the eradication of poliomyelitis."
01/01/2014 - "Suboptimal seroprevalence in the AFP cases confirmed that a high level of immunization against polio must be assured in our country, because the risk of importation and subsequent transmission of the poliovirus remains until polio is globally eradicated."
02/01/2015 - "An opportunity exists for INoPSU to suggest a standard way for member countries to collect AFP data in order to examine the potential for strengthening the current systems or introducing additional enterovirus surveillance or alternative/complementary neurological performance measures suitable for countries that have eliminated polio. "
01/01/1994 - "As the prevalence of wild poliovirus declines in China, reliable laboratory support needs to be established and adequately sensitive and specific AFP surveillance be developed if poliomyelitis is to be eradicated."
01/01/2014 - "AFP surveillance remains the gold standard method for poliomyelitis detection. "
|3.||Oral Poliovirus Vaccine (Sabin Vaccine)IBA
04/12/2007 - "After poliomyelitis has been eradicated, access to live polioviruses will be highly restricted and the use of oral poliovirus vaccine (OPV) will probably be discontinued. "
05/01/1984 - "Oral poliovirus vaccine administered during the first year of life has been effective in controlling poliomyelitis in tropical Africa."
10/01/1984 - "The present study showed that the neurovirulence test for the lesion-inducing virus dose in the spinal cord in 50% of monkeys inoculated with oral polio-vaccine (Sabin) (LID50) reflected to a large extent safety and efficacy of the vaccine upon administration to children. "
01/01/1981 - "Field trial on the efficacy of oral Sabin vaccine versus Salk polio vaccine."
09/28/2007 - "However, because vaccine-derived polioviruses (VDPVs) can produce polio outbreaks in areas with low rates of Sabin oral poliovirus vaccine (OPV) coverage and can replicate for years in immunodeficient persons, enhanced strategies are needed to limit emergence of VDPVs and stop all use of OPV once WPV transmission is eliminated. "
|4.||Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link
01/01/2004 - "There are further uncertainties concerning the possible role and efficacy of inactivated poliovirus vaccine (IPV) used either routinely or in outbreak control in low-hygiene settings, the potential for rapid geographical spread of polioviruses should an outbreak occur after certification, and the risks inherent in introducing additional oral polio vaccine (OPV) viruses into populations in which the vaccine coverage and prevalence of immunity have declined, and which may thus favour the spread of VDPVs. "
04/15/1999 - "The inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis in The Netherlands. "
09/01/1997 - "In The Netherlands the inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis. "
12/01/1991 - "Inactivated poliovirus vaccine (IPV) is the vaccine of choice for protection against paralytic poliomyelitis provided that it is used within the context of a program to increase and sustain the level of uptake to as close to 100% as possible. "
04/23/1988 - "The 1986-87 outbreak of paralytic poliomyelitis in Senegal, with 676 reported cases, provided an opportunity to evaluate the efficacy of an enhanced-potency inactivated poliovirus vaccine (N-IPV) in the Kolda region, where this vaccine has been used since 1980. "
08/01/1995 - "The vaccine efficacy against poliomyelitis was 96% for serotype I, 100% for serotype II and 97-98% for serotype III. Of the infants in both groups, 97% had antibodies against B. "
02/01/2015 - "This study measured seroprevalence of antibodies against poliovirus serotypes 1 to 3 (PV1, PV2 and PV3) in 7-month-old infants who had received at least 4 doses of trivalent oral polio vaccine. "
04/08/2013 - "A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan."
11/01/2009 - "The study of strain-specific antibodies to vaccine-derived and wild polioviruses has demonstrated that wild poliomyelitis viruses have not circulated in the areas of the examinees in the past decade."
05/05/2009 - "This study evaluated the seroprevalence of poliovirus types 1, 2 and 3 antibodies and vaccination coverage in 780 subjects aged between 7 months and 39 years in Montevideo, Uruguay, where oral polio vaccine (OPV) is used. "
|6.||Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA
07/01/1962 - "Studies on combined adsorbed poliomyelitis-DTP vaccine. "
09/01/2014 - "High dropout rates in the uptake of oral polio vaccine (OPV) and DTP vaccine persist despite efforts to improve immunisation coverage. "
01/01/2012 - "The rates by individual vaccine were similar across townships (p >0.05), except for diphtheria/tetanus/pertussis vaccine (p=0.02) and oral polio vaccine (p <0.01). "
01/01/2001 - "During the interval between the cessation of wild virus transmission and the global stoppage of polio vaccination, it will be advantageous to use IPV, particularly combined with DPT vaccine, to provide individual protection, and herd effect to prevent spread in case of the introduction of wild polioviruses, whether unintentionally or otherwise, and to bolster the Expanded Programme on Immunisation."
11/01/1993 - "The proportions of infants on whom immunisation was initiated, were very high for DPT vaccine (88-99%) and polio vaccine (85-99%); however, of those who had received the first dose, 23-39 per cent did not complete the 3-dose schedule. "
01/21/2013 - "There are two highly efficacious poliovirus vaccines: Sabin's live-attenuated oral polio vaccine (OPV) and Salk's inactivated polio vaccine (IPV). "
01/01/1980 - "Reliable laboratory techniques for the intratypic characterization of poliovirus types 1, 2, and 3 isolates have an important role in the epidemiological surveillance of poliomyelitis and in studies of the safety and efficacy of poliovirus vaccines. "
01/01/1980 - "Poliovirus vaccines (Salk-type and Sabin-type) have virtually eliminated paralytic poliomyelitis. "
01/01/1979 - "Benefit/risk factors in immunization against poliomyelitis are examined from the viewpoint of the relative risk and efficacy of killed and live poliovirus vaccines in the currently changing contexts of poliomyelitis prevalence in developed and developing countries. "
08/01/1998 - "To study the effect of an educational videotape about poliovirus vaccines and choices of schedules for parents/guardians of children starting the polio vaccination series. "
01/01/2015 - "This study measured polio virus neutralizing antibody levels among children in North-central and South-western Nigeria. "
01/01/2007 - "The persistence of poliovirus-neutralizing antibodies was investigated in 297 individuals residing in Argentina who had completed the vaccination cycle with four or five oral polio vaccine (OPV) doses 1 mo to 19 yr before this study. "
01/01/1992 - " Because little is known about seroconversion rates of polio neutralizing antibodies to greater than 5 doses of OPV, and because it is believed that 3-4 doses of OPV by routine services may not be adequate to eradicate polio globally, the study's findings will have important ramifications for global efforts to eradicate polio. "
01/01/1992 - " The study in Cuba seeks to determine the seroprevalence of polio neutralizing antibodies (types 1, 2, and 3) in children under 5 years of age. "
11/01/1991 - "A study of poliomyelitis neutralizing antibodies was carried out on 165 samples of blood serum drawn from subjects aged 14-15 years who had completed vaccination with OPV 11 or 12 years ago. "
05/09/2005 - "Significantly (p < or =0.0001) higher antibody levels against diphtheria and the 3 polio components were also induced by Infanrix hexa. "
10/01/2010 - "Available clinical data from more than 10 years' experience with the vaccine suggest that Infanrix hexa as primary and booster vaccination is a safe and useful option for providing protection against the common childhood diseases of diphtheria, tetanus, poliomyelitis, pertussis, hepatitis B and invasive Hib disease."
05/28/2010 - "Available clinical data from more than 10 years' experience with the vaccine suggest that Infanrix hexa as primary and booster vaccination is a safe and useful option for providing protection against the common childhood diseases of diphtheria, tetanus, poliomyelitis, pertussis, hepatitis B and invasive Hib disease."
10/01/2010 - "Infanrix hexa, administered intramuscularly, is a diphtheria, tetanus, acellular pertussis, hepatitis B (HBV), inactivated poliomyelitis and Haemophilus influenzae type b (Hib) conjugate vaccine, indicated for primary and booster vaccination of infants. "
05/28/2010 - "Infanrix hexa, administered intramuscularly, is a diphtheria, tetanus, acellular pertussis, hepatitis B (HBV), inactivated poliomyelitis and Haemophilus influenzae type b (Hib) conjugate vaccine, indicated for primary and booster vaccination of infants. "
10/07/1963 - "AN IMPROVED METHOD FOR CONCENTRATING AND PURIFYING POLIO ANTIGEN WITH THE MIXED BED ION EXCHANGER (BRIEF REPORT)]."
12/01/2004 - "Polio and non-polio antigen coverage increased in seven countries during the study period. "
01/01/1979 - "Study of the HLA antigen in Arab children with paralytic poliomyelitis."
11/01/1964 - "[STUDIES ON THE MECHANISM OF DEVELOPMENT OF A NON-INFECTIVE "ACRIDINE" POLIO-ANTIGEN]."
01/01/1962 - "[Study of the stability of the poliomyelitis antigen in tetravalent vaccine]."
05/01/1984 - "Injectable polio vaccine, although found to be highly effective in routine immunization programs, is very costly and in short supply. "
04/01/2015 - "A randomized clinical trial platform evaluated the efficacy of delayed-dose oral rotavirus vaccine as well as the benefit of an injectable polio vaccine replacing one dose of oral polio vaccine. "
04/01/2003 - "Our study confirms that injections administered during the poliovirus incubation period can provoke paralytic poliomyelitis. "
03/01/1992 - "This study confirms that injections are an important cause of provocative poliomyelitis. "
01/01/1991 - "The results of the study of postvaccinal immunity to poliomyelitis suggest that during the first and second year of life the course of vaccination against poliomyelitis may be reduced to 3 injections."
|2.||Transplantation (Transplant Recipients)
08/01/1959 - "[Physiological studies of the remote results of tendon and muscle transplantation in poliomyelitis]."
01/01/2002 - "Shoulder fusion and free-functioning gracilis transplantation for biceps replacement provide a solution for restoration of function in children with flail shoulder and elbow, as caused by poliomyelitis. "
10/01/1991 - "Immune response to polio vaccination in bone marrow transplant recipients."
02/01/1991 - "Response to immunization against polio after allogeneic marrow transplantation."
09/01/1966 - "[Transplantation of the extensor muscles of the toes onto the metatarsal bones in the treatment of the poliomyelitis foot]."
09/01/2014 - "This study reports an original case of bilateral custom-fit hinged total knee arthroplasty in a patient with poliomyelitis. "
09/01/2014 - "Only 5 studies (Patterson and Insall; Moran; Giori and Lewallen; Jordan et al; and Tigani et al) have reported total knee arthroplasty results in patients with poliomyelitis. "
05/01/2015 - "Total knee arthroplasty (TKA) in limbs affected by poliomyelitis is a technically challenging procedure. "
05/01/2015 - "Custom rotating hinge total knee arthroplasty in patients with poliomyelitis affected limbs."
09/01/2014 - "Bilateral custom-fit total knee arthroplasty in a patient with poliomyelitis."
|4.||Activities of Daily Living (ADL)
06/01/2013 - "By now polio is eradicated, but persons with difficulty to perform activities of daily living due to a limited arm function still exist. "
10/15/2014 - "Higher disability in ADL and mobility and lower perception of physical and mental health in polio survivors were associated with a higher score on the IPPS, reflecting greater severity of polio sequelae. "
09/01/2006 - "PPS is recognised as being a specific neurological syndrome that appears several decades after the acute episode of polio; it exacerbates the motor sequelae already present in these patients and reduces their functional capacity to a point where it affects their activities of daily living. "
06/01/1996 - "After an attack of acute poliomyelitis, muscular strength can continue to improve for up to two and a half years, while ADL usually remain stable after one and a half years and mobility after one year."
11/01/2009 - "Information was gathered by questionnaire and interview on demographics, age at polio onset, affected body parts, health problems, the use of assistive devices, housing condition and activities of daily living (ADL) function as well as perceived difficulties. "
03/01/2003 - "We therefore conclude that moderate intensity strength training is safe and effective in post-polio patients."
03/01/2003 - "The purpose of this study was to test the hypotheses that: (1) after strength training, post-polio patients show strength improvement comparable to that seen in the healthy elderly; (2) such training does not have a deleterious effect on motor unit (MU) survival; and (3) part of the strength improvement is due to an increase in voluntary motor drive. "
03/01/2003 - "Randomized controlled trial of strength training in post-polio patients."
10/01/2008 - "Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a pilot study."